China Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT Genotype

NCT04974151 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

24000

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
MTHFR 677 TT Genotype

Interventions

DRUG: Amlodipine besylate
DRUG: Amlodipine besylate And Folic Acid
DRUG: 5-methyltetrahydrofolate (5-MTHF)
DRUG: Amlodipine placebo
DRUG: Amlodipine folic acid placebo
DRUG: 5-MTHF Placebos

Sponsor

Shenzhen Ausa Pharmed Co.,Ltd

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]